{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:55:02Z","timestamp":1786737302847,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jcrt.jcrt_34_18","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T00:15:24Z","timestamp":1609114524000},"page":"194","source":"Crossref","is-referenced-by-count":3,"title":["Long-term oncologic and complication outcomes in anal cancer patients treated with radiation therapy"],"prefix":"10.4103","volume":"16","author":[{"given":"JongHoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiHyeon","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-hong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SangMin","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinCheon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChangSik","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TaeWon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.263530-1","first-page":"354","volume-title":"Combined therapy for cancer of the anal canal: A preliminary report","author":"Nigro","year":"1974","journal-title":"Dis Colon Rectum"},{"key":"key-10.4103\/0973-1482.263530-2","first-page":"2527","volume-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.263530-3","doi-asserted-by":"crossref","unstructured":"Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr., et al. Fluorouracil, mitomycin, and radiotherapy vs. fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial. JAMA 2008;299:1914-21.","DOI":"10.1001\/jama.299.16.1914"},{"key":"key-10.4103\/0973-1482.263530-4","first-page":"516","volume-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): A randomised, phase 3, open-label, 2 \u00d7 2 factorial trial","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0973-1482.263530-5","first-page":"114","volume-title":", John M, Krieg R, Pinover W, Myerson R, et al. Evaluation of planned treatment breaks during radiation therapy for anal cancer: Update of RTOG 92-08","author":"Konski","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.4103\/0973-1482.263530-6","first-page":"1941","volume-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: Final analysis of the randomized UNICANCER ACCORD 03 trial","author":"Peiffert","year":"2012","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.263530-7","first-page":"552","volume-title":"Twenty-five-year experience with radical chemoradiation for anal cancer","author":"Tomaszewski","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.4103\/0973-1482.263530-8","first-page":"1115","volume-title":"Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C","author":"Cummings","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.4103\/0973-1482.263530-9","first-page":"651","volume-title":"Time-dose considerations in the treatment of anal cancer","author":"Constantinou","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.4103\/0973-1482.263530-10","first-page":"1136","volume-title":"Radiochemotherapy in the conservative treatment of anal canal carcinoma: Retrospective analysis of results and radiation dose effectiveness","author":"Ferrigno","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.4103\/0973-1482.263530-11","first-page":"1153","volume-title":"Radiotherapy for anal cancer: Experience from 1979-1987","author":"Hughes","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.4103\/0973-1482.263530-12","first-page":"209","volume-title":"Chemoradiation therapy for anal cancer: Radiation plus continuous infusion of 5-fluorouracil with or without cisplatin","author":"Rich","year":"1993","journal-title":"Radiother Oncol"},{"key":"key-10.4103\/0973-1482.263530-13","first-page":"2040","volume-title":"Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.263530-14","first-page":"4007","volume-title":", et al. Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: The intergroup trial (RTOG 98-11)","author":"Ajani","year":"2010","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.263530-15","first-page":"4344","volume-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: Survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.263530-16","first-page":"1098","volume-title":"Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation","author":"Ajani","year":"2010","journal-title":"Dig Dis Sci"},{"key":"key-10.4103\/0973-1482.263530-17","first-page":"4581","volume-title":"Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: A multicenter experience","author":"Salama","year":"2007","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.263530-18","first-page":"424","volume-title":"Concurrent chemotherapy and intensity-modulated radiation therapy for anal carcinoma \u2013 Clinical outcomes in a large national cancer institute-designated integrated cancer centre network","author":"DeFoe","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key-10.4103\/0973-1482.263530-19","first-page":"110","volume-title":"Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529","author":"Mitra","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"key-10.4103\/0973-1482.263530-20","first-page":"155","volume-title":"Organ-sparing intensity-modulated radiotherapy for anal cancer using the ACTII schedule: A comparison of conventional and intensity-modulated radiotherapy plans","author":"Brooks","year":"2013","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key-10.4103\/0973-1482.263530-21","first-page":"354","volume-title":"Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome","author":"Milano","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.4103\/0973-1482.263530-22","first-page":"77","volume-title":"Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: Experience in a series of 270 patients treated in Lyon and review of the literature","author":"Gerard","year":"2001","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.263530-23","first-page":"794","volume-title":"Predictors and patterns of recurrence after definitive chemoradiation for anal cancer","author":"Das","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:52:46Z","timestamp":1786733566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_34_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"alternative-id":["263530"],"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_34_18","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}